Skip to main content
OLIPASS CORPORATION logo

OLIPASS CORPORATION — Investor Relations & Filings

Ticker · 244460 ISIN · KR7244460002 KO Professional, scientific and technical activities
Open in API
Filings indexed 507 across all filing types
Latest filing 2024-12-26 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 244460

About OLIPASS CORPORATION

https://www.olipass.com/front/eng/index…

OLIPASS CORPORATION is a research and development company focused on creating RNA therapeutics. The company's core activities are centered on its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. OPNA is a novel technology derived from Peptide Nucleic Acid (PNA) by introducing a cationic lipid moiety onto the nucleobase. This structural modification is designed to markedly improve cell permeability, a key challenge in nucleic acid-based drug delivery. The platform is optimized to induce exon skipping by specifically binding to target pre-mRNA inside the cell nucleus, enabling the discovery and development of new therapeutic candidates.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Olipass Co., Ltd. regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the amendment of payment dates and listing dates for new shares, which constitutes a capital structure change. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2024-12-26 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's representative directors (CEO/Management). It explicitly lists the 'before' and 'after' status of the representative directors, the reason for the change (term expiration), and the effective date. This aligns perfectly with the definition for Board/Management Information (MANG).
2024-12-20 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and the closure of the shareholder register for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting. It does not contain the full meeting materials or proxy statements, but rather serves as a formal regulatory notice of administrative action. Given the nature of the announcement, it fits best under the general regulatory filing category.
2024-12-13 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the amendment of payment dates and share issuance schedules for a third-party allocation capital increase. This falls under the category of share issuance and capital changes.
2024-12-13 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korea Exchange regarding a decision to issue new shares through a third-party allocation (유상증자결정). This document details the purpose of the capital increase, the issuance price, the target entity (XenoCure), and the impact on the company's shareholding structure. This falls under the category of share issuance and capital changes.
2024-12-06 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange (KRX) regarding a decision to issue new shares through a third-party allocation (유상증자결정). This type of filing is a formal announcement of a capital change/share issuance. According to the provided definitions, announcements regarding new share issues or capital changes are classified as 'SHA'.
2024-12-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.